Overview maps RNA vaccines and DNA vaccines. Pfizer–BioNTech (original) Pfizer–BioNTech (omicron) Moderna (original) Moderna (omicron) Others. Adenovirus vector vaccines. Oxford–AstraZeneca. Janssen. Sputnik V. Sputnik Light. Convidecia. iNCOVACC.
The updated mRNA COVID-19 vaccines include Comirnaty and Spikevax, both of which are approved for individuals 12 years of age and older, and the Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine, both of which are authorized for emergency use for individuals 6 months through 11 years of age.
Recommended COVID-19 Vaccines VaccineRecommended for: 2024–2025 Moderna COVID-19 Vaccine Everyone ages 6 months and older 2024–2025 Pfizer-BioNTech COVID-19 Vaccine Everyone ages 6 months and older 2024–2025 Novavax COVID-19 Vaccine Everyone ages 12 years and older
Moderna. The FDA granted the Moderna vaccine (brand name: Spikevax) full approval for people 18 and older in January 2022, upgrading the vaccine's EUA, which was granted in December 2020 (a week after Pfizer-BioNTech).
There is no preference for one vaccine over the other when more than one vaccine is recommended for an age group. The 2024–2025 COVID-19 vaccines more closely target the JN.1 lineage of the Omicron variant. 2024–2025 COVID-19 vaccines are updated to give you the best protection from the currently circulating strains.
COVID-19 vaccines Pfizer-BioNTech COVID-19 vaccine 2024-2025 formula, available for people age 6 months and older. Moderna COVID-19 vaccine 2024-2025 formula, available for people age 6 months and older. Novavax COVID-19 vaccine, adjuvanted 2024-2025 formula, available for people age 12 years and older.
There are several types of vaccines, including: Inactivated vaccines. Live-attenuated vaccines. Messenger RNA (mRNA) vaccines. Subunit, recombinant, polysaccharide, and conjugate vaccines. Toxoid vaccines. Viral vector vaccines.
There is a new strain called XEC that is emerging and causing infections. It's a subvariant of the SARS-CoV-2 Omicron strain and is made up of combinations of two pre-existing COVID-19 subvariants (KP. 3.3 and KS.
People are considered fully vaccinated for COVID-19: two weeks or more after they have received the second dose in a 2-dose series (Pfizer-BioNTech or Moderna or other vaccine authorized by the World Health Organization), or two weeks or more after they have received a single-dose vaccine (Johnson and Johnson J&J/ ...
Following the summer COVID-19 surge, the Food and Drug Administration recently approved two updated mRNA COVID-19 vaccines: Moderna (Spikevax) and Pfizer-BioNTech (Comirnaty).